• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

利用补充癌症登记数据评估局限性前列腺癌的治疗趋势。

Trends in the treatment of localized prostate cancer using supplemented cancer registry data.

机构信息

Keck School of Medicine, University of Southern California, Los Angeles, CA, USA.

出版信息

BJU Int. 2011 Feb;107(4):576-84. doi: 10.1111/j.1464-410X.2010.09514.x. Epub 2010 Aug 24.

DOI:10.1111/j.1464-410X.2010.09514.x
PMID:20735387
Abstract

OBJECTIVE

To conduct an analysis of localized prostate cancer treatment in the USA between 1998 and 2002.

PATIENTS AND METHODS

Results from the National Cancer Institute's Patterns of Care study from 10 regional cancer registries in 1998 and 14 registries in 2002 were compared using univariate and multivariate statistical methods.

RESULTS

Patients with localized prostate cancer in 2002 were younger, had lower prostate-specific antigen values, and higher Gleason scores compared with those diagnosed in 1998. Little change occurred in age-adjusted percentages of men who were treated with a radical prostatectomy (45-46%) or by external beam radiation (EBRT) alone (19-20%). The proportion receiving brachytherapy (BT), alone or with EBRT, increased from 14.9 to 17.7%, while the proportion receiving watchful waiting declined from 12.6 to 9.0%. Younger African-American men with intermediate/high-risk disease were less likely to receive any type of aggressive therapy in comparison with Non-Hispanic White men. Over 70% of men who were ≥ 75 years of age, with low-risk disease, were treated with EBRT or BT.

CONCLUSIONS

Older men with low-risk disease might be overtreated with aggressive therapy, while younger intermediate/high-risk African-American men appear less likely to receive indicated aggressive therapy.

摘要

目的

分析 1998 年至 2002 年间美国局限性前列腺癌的治疗情况。

患者和方法

比较了来自 1998 年 10 个地区癌症登记处和 2002 年 14 个登记处的美国国家癌症研究所模式护理研究的结果,使用单变量和多变量统计方法。

结果

2002 年诊断为局限性前列腺癌的患者比 1998 年诊断的患者年龄更小,前列腺特异性抗原值更低,Gleason 评分更高。接受根治性前列腺切除术(45-46%)或单纯外照射放疗(EBRT)治疗的男性比例在年龄调整后几乎没有变化(19-20%)。接受单纯或联合 EBRT 的近距离放射治疗(BT)的比例从 14.9%增加到 17.7%,而观察等待的比例从 12.6%下降到 9.0%。与非西班牙裔白人男性相比,患有中高危疾病的年轻非洲裔美国男性接受任何类型积极治疗的可能性较小。超过 70%年龄≥75 岁、低危疾病的男性接受 EBRT 或 BT 治疗。

结论

患有低危疾病的老年男性可能过度接受积极治疗,而年轻的中高危非洲裔美国男性似乎不太可能接受有指征的积极治疗。

相似文献

1
Trends in the treatment of localized prostate cancer using supplemented cancer registry data.利用补充癌症登记数据评估局限性前列腺癌的治疗趋势。
BJU Int. 2011 Feb;107(4):576-84. doi: 10.1111/j.1464-410X.2010.09514.x. Epub 2010 Aug 24.
2
Management of localised prostate cancer: watchful waiting, surgery or radiation therapy, depending on the natural course, which is often relatively slow.局限性前列腺癌的治疗:根据其自然病程(通常进展相对缓慢),可选择观察等待、手术或放射治疗。
Prescrire Int. 2012 Oct;21(131):242-8.
3
Racial treatment trends in localized/regional prostate carcinoma: 1992-1999.1992 - 1999年局限性/区域性前列腺癌的种族治疗趋势
Cancer. 2005 Feb 1;103(3):538-45. doi: 10.1002/cncr.20796.
4
A population-based analysis of contemporary patterns of care in younger men (<60 years old) with localized prostate cancer.一项基于人群的对60岁以下局限性前列腺癌年轻男性当代护理模式的分析。
Int Urol Nephrol. 2015 Oct;47(10):1629-34. doi: 10.1007/s11255-015-1096-8. Epub 2015 Sep 2.
5
Contemporary prostate cancer treatment choices in multidisciplinary clinics referenced to national trends.多学科诊所中参考国家趋势的当代前列腺癌治疗选择。
Cancer. 2020 Feb 1;126(3):506-514. doi: 10.1002/cncr.32570. Epub 2019 Nov 19.
6
Racial differences in initial treatment for clinically localized prostate cancer. Results from the prostate cancer outcomes study.临床局限性前列腺癌初始治疗中的种族差异。前列腺癌结局研究的结果。
J Gen Intern Med. 2003 Oct;18(10):845-53. doi: 10.1046/j.1525-1497.2003.21105.x.
7
Long-term Prostate Cancer-specific Mortality After Prostatectomy, Brachytherapy, External Beam Radiation Therapy, Hormonal Therapy, or Monitoring for Localized Prostate Cancer.前列腺癌根治术后、近距离放射治疗、外照射治疗、激素治疗或局部前列腺癌监测后的长期前列腺癌特异性死亡率。
Eur Urol. 2024 Jun;85(6):565-573. doi: 10.1016/j.eururo.2023.09.024. Epub 2023 Oct 17.
8
Use of Active Surveillance or Watchful Waiting for Low-Risk Prostate Cancer and Management Trends Across Risk Groups in the United States, 2010-2015.美国 2010-2015 年低危前列腺癌的主动监测或观察等待使用情况和各风险组的管理趋势
JAMA. 2019 Feb 19;321(7):704-706. doi: 10.1001/jama.2018.19941.
9
Patient-Reported Outcomes Through 5 Years for Active Surveillance, Surgery, Brachytherapy, or External Beam Radiation With or Without Androgen Deprivation Therapy for Localized Prostate Cancer.局部前列腺癌主动监测、手术、近距离放疗或外照射放疗联合或不联合雄激素剥夺治疗 5 年的患者报告结局。
JAMA. 2020 Jan 14;323(2):149-163. doi: 10.1001/jama.2019.20675.
10
Contemporary Management of Prostate Cancer Patients Suitable for Active Surveillance: A North American Population-based Study.适合主动监测的前列腺癌患者的当代管理:一项北美基于人群的研究。
Eur Urol Focus. 2018 Jan;4(1):68-74. doi: 10.1016/j.euf.2016.06.001. Epub 2016 Jun 14.

引用本文的文献

1
Single-Port Versus Multi-Port Robotic Radical Prostatectomy in Elderly Patients.老年患者单孔与多孔机器人根治性前列腺切除术
Cancers (Basel). 2025 May 31;17(11):1857. doi: 10.3390/cancers17111857.
2
Randomized phase II trial of MRI-guided salvage radiotherapy for prostate cancer in 4 weeks versus 2 weeks (SHORTER).随机 2 期临床试验:4 周与 2 周 MRI 引导下前列腺癌挽救性放疗(更短时间)。
BMC Cancer. 2023 Aug 22;23(1):781. doi: 10.1186/s12885-023-11278-3.
3
Overcoming Drug Resistance in Advanced Prostate Cancer by Drug Repurposing.
通过药物再利用克服晚期前列腺癌的耐药性。
Med Sci (Basel). 2022 Feb 18;10(1):15. doi: 10.3390/medsci10010015.
4
Oncologic outcome of radical prostatectomy versus radiotherapy as primary treatment for high and very high risk localized prostate cancer.根治性前列腺切除术与放疗作为高风险和极高风险局限性前列腺癌的主要治疗方法的肿瘤学结果。
Prostate. 2021 Mar;81(4):223-230. doi: 10.1002/pros.24089. Epub 2021 Jan 20.
5
Active treatment in low-risk prostate cancer: a population-based study.低危前列腺癌的积极治疗:一项基于人群的研究。
Curr Oncol. 2019 Aug;26(4):e535-e540. doi: 10.3747/co.26.4953. Epub 2019 Aug 1.
6
Treatment and Survival Disparities in the National Cancer Institute's Patterns of Care Study (1987-2017).美国国立癌症研究所照护模式研究(1987 - 2017年)中的治疗与生存差异
Cancer Invest. 2018;36(6):319-329. doi: 10.1080/07357907.2018.1474894. Epub 2018 Aug 23.
7
More Judicious Use of Expectant Management for Localized Prostate Cancer during the Last 2 Decades.在过去 20 年中,更明智地使用期待治疗管理局限性前列腺癌。
J Urol. 2017 Mar;197(3 Pt 1):614-620. doi: 10.1016/j.juro.2016.10.067. Epub 2016 Oct 27.
8
Utilization of prostate brachytherapy for low risk prostate cancer: Is the decline overstated?低危前列腺癌前列腺近距离放射治疗的应用:其使用量的下降是否被夸大了?
J Contemp Brachytherapy. 2016 Aug;8(4):289-93. doi: 10.5114/jcb.2016.61942. Epub 2016 Aug 23.
9
Patients' Survival Expectations With and Without Their Chosen Treatment for Prostate Cancer.前列腺癌患者接受和不接受其选择的治疗时的生存预期。
Ann Fam Med. 2016 May;14(3):208-14. doi: 10.1370/afm.1926.
10
Racial Differences in Treatment Decision-Making for Men with Clinically Localized Prostate Cancer: a Population-Based Study.种族差异对临床局限性前列腺癌男性治疗决策的影响:一项基于人群的研究。
J Racial Ethn Health Disparities. 2016 Mar;3(1):35-45. doi: 10.1007/s40615-015-0109-8. Epub 2015 May 5.